Literature DB >> 21742061

The altered activity of complex III may contribute to the high penetrance of Leber's hereditary optic neuropathy in a Chinese family carrying the ND4 G11778A mutation.

Yaping Qian1, Xiangtian Zhou, Min Liang, Jia Qu, Min-Xin Guan.   

Abstract

The ND4 G11778A mutation is the most common mitochondrial DNA mutation leading to Leber's hereditary optic neuropathy (LHON). Despite considerable clinical evidences, the modifier role of nuclear background and mitochondrial haplotypes in phenotypic manifestation of LHON remains poorly understood. We investigated the effect of these modifiers on bioenergetics in lymphoblastoid cell lines derived from five affected subjects of one Chinese family carrying the G11778A mutation and five Chinese controls. Significant reductions in the activities of complexes I and III were observed in mutant cell lines from the Chinese family, whereas the mutant cell lines from other families carrying the same mutation exhibited only reduced activity of complex I. The reduced activities of complexes I and III caused remarkably higher reductions of ATP synthesis in mutant cell lines from the Chinese family than those from other families. The deficient respiration increased generation of reactive oxygen species. The defect in complex III activity, likely resulting from the mitochondrial haplotype or nuclear gene alteration, worsens mitochondrial dysfunction caused by the G11778A mutation, thereby causing extremely high penetrance and expressivity of optic neuropathy in this Chinese family. Our data provide the first experimental evidence that altered activity of complex III modulates the phenotypic manifestation of LHON-associated G11778A mutation. Thus, our findings may provide new insights into the pathophysiology of LHON. Copyright Â
© 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742061     DOI: 10.1016/j.mito.2011.06.006

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  10 in total

1.  Coronary heart disease is associated with a mutation in mitochondrial tRNA.

Authors:  Zidong Jia; Xinjian Wang; Yanwen Qin; Ling Xue; Pingping Jiang; Yanzi Meng; Suxue Shi; Yan Wang; Jun Qin Mo; Min-Xin Guan
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

2.  Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation.

Authors:  Feilong Meng; Xiaohui Cang; Yanyan Peng; Ronghua Li; Zhengyue Zhang; Fushan Li; Qingqing Fan; Anna S Guan; Nathan Fischel-Ghosian; Xiaoli Zhao; Min-Xin Guan
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

3.  Complex I mutations synergize to worsen the phenotypic expression of Leber's hereditary optic neuropathy.

Authors:  Yanchun Ji; Juanjuan Zhang; Yuanyuan Lu; Qiuzi Yi; Mengquan Chen; Shipeng Xie; Xiaoting Mao; Yun Xiao; Feilong Meng; Minglian Zhang; Rulai Yang; Min-Xin Guan
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

4.  Mitochondrial haplotypes may modulate the phenotypic manifestation of the LHON-associated ND1 G3460A mutation in Chinese families.

Authors:  Yanchun Ji; Min Liang; Juanjuan Zhang; Minglian Zhang; Jinping Zhu; Xiangjuan Meng; Sai Zhang; Min Gao; Fuxin Zhao; Qi-Ping Wei; Pingping Jiang; Yi Tong; Xiaoling Liu; Jun Qin Mo; Min-Xin Guan
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

5.  Biochemical evidence for a mitochondrial genetic modifier in the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation.

Authors:  Pingping Jiang; Min Liang; Chaofan Zhang; Xiaoxu Zhao; Qiufen He; Limei Cui; Xiaoling Liu; Yan-Hong Sun; Qun Fu; Yanchun Ji; Yidong Bai; Taosheng Huang; Min-Xin Guan
Journal:  Hum Mol Genet       Date:  2016-07-17       Impact factor: 6.150

6.  PRICKLE3 linked to ATPase biogenesis manifested Leber's hereditary optic neuropathy.

Authors:  Jialing Yu; Xiaoyang Liang; Yanchun Ji; Cheng Ai; Junxia Liu; Ling Zhu; Zhipeng Nie; Xiaofen Jin; Chenghui Wang; Juanjuan Zhang; Fuxin Zhao; Shuang Mei; Xiaoxu Zhao; Xiangtian Zhou; Minglian Zhang; Meng Wang; Taosheng Huang; Pingping Jiang; Min-Xin Guan
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

7.  Leber's hereditary optic neuropathy is associated with the T3866C mutation in mitochondrial ND1 gene in three Han Chinese Families.

Authors:  Xiangtian Zhou; Yaping Qian; Juanjuan Zhang; Yi Tong; Pingping Jiang; Min Liang; Xianning Dai; Huihui Zhou; Fuxin Zhao; Yanchun Ji; Jun Qin Mo; Jia Qu; Min-Xin Guan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-09       Impact factor: 4.799

8.  A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions.

Authors:  Rafik Z Fayzulin; Michael Perez; Natalia Kozhukhar; Domenico Spadafora; Glenn L Wilson; Mikhail F Alexeyev
Journal:  Nucleic Acids Res       Date:  2015-03-27       Impact factor: 16.971

9.  Profiling the mitochondrial proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: down-regulation of bioenergetics and mitochondrial protein quality control pathways in fibroblasts with the 11778G>A mutation.

Authors:  Aung Win Tun; Sakdithep Chaiyarit; Supannee Kaewsutthi; Wanphen Katanyoo; Wanicha Chuenkongkaew; Masayoshi Kuwano; Takeshi Tomonaga; Chayanon Peerapittayamongkol; Visith Thongboonkerd; Patcharee Lertrit
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  A novel ADOA-associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis.

Authors:  Juanjuan Zhang; Xiaoling Liu; Xiaoyang Liang; Yuanyuan Lu; Ling Zhu; Runing Fu; Yanchun Ji; Wenlu Fan; Jie Chen; Bing Lin; Yimin Yuan; Pingping Jiang; Xiangtian Zhou; Min-Xin Guan
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.